Ketonuria is not associated with hyperemesis gravidarum disease severity



      To assess the association between ketonuria and hyperemesis gravidarum (HG) disease severity.

      Study design

      We included pregnant women hospitalised for HG who participated in the Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding (MOTHER) trial and women who were eligible, chose not to be randomised and agreed to participate in the observational cohort. Between October 2013 and March 2016, in 19 hospitals in the Netherlands, women hospitalised for HG were approached for study participation. The presence of ketonuria was not required for study entry. Ketonuria was measured at hospital admission with a dipstick, which distinguishes 5 categories: negative and 1+ through 4 + . The outcome measures were multiple measures of HG disease severity at different time points: 1) At hospital admission (study entry): severity of nausea and vomiting, quality of life and weight change compared to pre-pregnancy weight, 2) One week after hospital admission: severity of nausea and vomiting, quality of life and weight change compared to admission, 3) Duration of index hospital admission and readmission for HG at any time point


      215 women where included. Ketonuria was not associated with severity of nausea and vomiting, quality of life or weight loss at hospital admission, nor was the degree of ketonuria at admission associated with any of the outcomes 1 week after hospital admission. The degree of ketonuria was also not associated with the number of readmissions. However, women with a higher degree of ketonuria had a statistically significant longer duration of hospital stay (per 1+ ketonuria, difference: 0.27 days, 95 % CI: 0.05 to 0.48).


      There was no association between the degree of ketonuria at admission and severity of symptoms, quality of life, maternal weight loss, or number of readmissions, suggesting that ketonuria provides no information about disease severity or disease course. Despite this, women with a higher degree of ketonuria at admission were hospitalised for longer. This could suggest that health care professionals base length of hospital stay on the degree of ketonuria. Based on the lack of association between ketonuria and disease severity, we suggest it has no additional value in the clinical management of HG.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Niebyl J.R.
        Clinical practice. Nausea and vomiting in pregnancy.
        N Engl J Med. 2010; 363: 1544-1550
        • Bailit J.L.
        Hyperemesis gravidarium: epidemiologic findings from a large cohort.
        Am J Obstet Gynecol. 2005; 193: 811-814
        • Veenendaal M.V.
        • van Abeelen A.F.
        • Painter R.C.
        • van der Post J.A.
        • Roseboom T.J.
        Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis.
        BJOG. 2011; 118: 1302-1313
        • Vikanes A.
        • Grjibovski A.M.
        • Vangen S.
        • Magnus P.
        Variations in prevalence of hyperemesis gravidarum by country of birth: a study of 900,074 pregnancies in Norway, 1967-2005.
        Scand J Public Health. 2008; 36: 135-142
        • Matsuo K.
        • Ushioda N.
        • Nagamatsu M.
        • Kimura T.
        Hyperemesis gravidarum in Eastern Asian population.
        Gynecol Obstet Invest. 2007; 64: 213-216
        • Niebyl J.R.
        Nausea and vomiting in pregnancy.
        N Engl J Med. 2010; 363: 1544-1550
        • Gazmararian J.A.
        • Petersen R.
        • Jamieson D.J.
        • Schild L.
        • Adams M.M.
        • Deshpande A.D.
        • et al.
        Hospitalizations during pregnancy among managed care enrollees.
        Obstet Gynecol. 2002; 100: 94-100
        • Piwko C.
        • Koren G.
        • Babashov V.
        • Vicente C.
        • Einarson T.R.
        Economic burden of nausea and vomiting of pregnancy in the USA.
        J Popul Ther Clin Pharmacol. 2013; 20: e149-60
        • Piwko C.
        • Ungar W.J.
        • Einarson T.R.
        • Wolpin J.
        • Koren G.
        The weekly cost of nausea and vomiting of pregnancy for women calling the Toronto Motherisk Program.
        Curr Med Res Opin. 2007; 23: 833-840
        • McCarthy F.P.
        • Lutomski J.E.
        • Greene R.A.
        Hyperemesis gravidarum: current perspectives.
        Int J Womens Health. 2014; 6: 719-725
        • Niemeijer M.N.
        • Grooten I.J.
        • Vos N.
        • Bais J.M.
        • van der Post J.A.
        • Mol B.W.
        • et al.
        Diagnostic markers for hyperemesis gravidarum: a systematic review and metaanalysis.
        Am J Obstet Gynecol. 2014; 211 (e1-15): 150
        • Grooten I.J.
        • Roseboom T.J.
        • Painter R.C.
        Barriers and challenges in hyperemesis gravidarum research.
        Nutr Metab Insights. 2015; 8: 33-39
        • Koot M.H.
        • Boelig R.C.
        • van’ t Hooft J.
        • Limpens J.
        • Roseboom T.J.
        • Painter R.C.
        • et al.
        Variation in hyperemesis gravidarum definition and outcome reporting in randomised clinical trials: a systematic review.
        BJOG. 2018;
        • Comstock J.P.
        • Garber A.J.
        Walker H.K. Hall W.D. Hurst J.W. Ketonuria. Clinical methods: the history, physical, and laboratory examinations. 3rd edition. Butterworths, Boston1990 (Chapter 140. Available from:)
        • Shehmar M.
        • MacLean M.A.
        • Nelson-Piercy C.
        • Gadsby R.
        • O’Hara M.
        The management of nausea and vomiting of pregnancy and hyperemesis gravidarum.
        ([cited 2018 August 6]. Available from:)2016
        • Beentjes M.M.
        • Weersma R.L.S.
        • Koch W.
        • Offringa A.K.
        • Verduijn M.M.
        • Mensink P.A.S.K.
        • et al.
        NHG-Standaard Zwangerschap en kraamperiode (tweede herziening).
        Huisarts Wet. 2012; 55: 112-125
        • Tayfur C.
        • Burcu D.C.
        • Gulten O.
        • Betul D.
        • Tugberk G.
        • Onur O.
        • et al.
        Association between platelet to lymphocyte ratio, plateletcrit and the presence and severity of hyperemesis gravidarum.
        J Obstet Gynaecol Res. 2017; 43: 498-504
        • Morris Z.H.
        • Azab A.N.
        • Harlev S.
        • Plakht Y.
        Developing and validating a prognostic index predicting re-hospitalization of patients with Hyperemesis Gravidarum.
        Eur J Obstet Gynecol Reprod Biol. 2018; 225: 113-117
        • Tan P.C.
        • Tan N.C.
        • Omar S.Z.
        Effect of high levels of human chorionic gonadotropin and estradiol on the severity of hyperemesis gravidarum.
        Clin Chem Lab Med. 2009; 47: 165-171
        • Tan P.C.
        • Jacob R.
        • Quek K.F.
        • Omar S.Z.
        Readmission risk and metabolic, biochemical, haematological and clinical indicators of severity in hyperemesis gravidarum.
        Aust N Z J Obstet Gynaecol. 2006; 46: 446-450
        • Tan P.C.
        • Jacob R.
        • Quek K.F.
        • Omar S.Z.
        Indicators of prolonged hospital stay in hyperemesis gravidarum.
        Int J Gynaecol Obstet. 2006; 93: 246-247
        • Gan T.J.
        • Diemunsch P.
        • Habib A.S.
        • Kovac A.
        • Kranke P.
        • Meyer T.A.
        • et al.
        Consensus guidelines for the management of postoperative nausea and vomiting.
        Anesth Analg. 2014; 118
        • Tageja N.
        • Groninger H.
        Chemotherapy-induced nausea and vomiting: an overview and comparison of three consensus guidelines.
        Postgrad Med J. 2016; 92: 34
        • Grooten I.J.
        • Koot M.H.
        • van der Post J.A.
        • Bais J.M.
        • Ris-Stalpers C.
        • Naaktgeboren C.
        • et al.
        Early enteral tube feeding in optimizing treatment of hyperemesis gravidarum: the Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding (MOTHER) randomized controlled trial.
        Am J Clin Nutr. 2017; 106: 812-820
        • Kuscu N.K.
        • Yildirim Y.
        • Koyuncu F.
        • Var A.
        • Uyanik B.S.
        Interleukin-6 levels in hyperemesis gravidarum.
        Arch Gynecol Obstet. 2003; 269: 13-15
        • Koot M.H.
        • Grooten I.J.
        • Gauw N.E.
        • Roseboom T.J.
        • Painter R.C.
        [Hyperemesis gravidarum].
        Ned Tijdschr Geneeskd. 2019; : 163
        • Grooten I.J.
        • Mol B.W.
        • van der Post J.A.
        • Ris-Stalpers C.
        • Kok M.
        • Bais J.M.
        • et al.
        Early nasogastric tube feeding in optimising treatment for hyperemesis gravidarum: the MOTHER randomised controlled trial (Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding).
        BMC Pregnancy Childbirth. 2016; 16: 22
        • Magee L.A.
        • Chandra K.
        • Mazzotta P.
        • Stewart D.
        • Koren G.
        • Guyatt G.H.
        Development of a health-related quality of life instrument for nausea and vomiting of pregnancy.
        Am J Obstet Gynecol. 2002; 186: S232-8
        • Power Z.
        • Campbell M.
        • Kilcoyne P.
        • Kitchener H.
        • Waterman H.
        The Hyperemesis Impact of Symptoms Questionnaire: development and validation of a clinical tool.
        Int J Nurs Stud. 2010; 47: 67-77
        • Birkeland E.
        • Stokke G.
        • Tangvik R.J.
        • Torkildsen E.A.
        • Boateng J.
        • Wollen A.L.
        • et al.
        Norwegian PUQE (Pregnancy-Unique Quantification of Emesis and nausea) identifies patients with hyperemesis gravidarum and poor nutritional intake: a prospective cohort validation study.
        PLoS One. 2015; 10e0119962
        • Ebrahimi N.
        • Maltepe C.
        • Bournissen F.G.
        • Koren G.
        Nausea and vomiting of pregnancy: using the 24-hour Pregnancy-Unique Quantification of Emesis (PUQE-24) scale.
        J Obstet Gynaecol Can. 2009; 31: 803-807
        • Norman G.
        Likert scales, levels of measurement and the “laws” of statistics.
        Adv Health Sci Educ. 2010; 15: 625-632
        • Trovik J.
        • Vikanes A.
        Hyperemesis Gravidarum is associated with substantial economic burden in addition to severe physical and psychological suffering.
        Isr J Health Policy Res. 2016; 5: 43
        • Biggs J.S.G.
        Vomiting in pregnancy: causes and management.
        Drugs. 1975; 9: 299-306
        • Douglas H.J.
        Hyperemesis gravidarum.
        Dalhousie Med J. 1955; 08
        • Kim H.J.
        • Joo N.S.
        • Kim K.M.
        • Lee D.J.
        • Kim S.M.
        Different response of body weight change according to ketonuria after fasting in the healthy obese.
        J Korean Med Sci. 2012; 27: 250-254